Trial in Progress of Engot-Cx8/Gog-3024/Innovatv 205: Addition of A New Cohort Using First-Line Tisotumab Vedotin Plus Pembrolizumab Plus Carboplatin +/- Bevacizumab in Recurrent/Metastatic Cervical Cancer

dc.contributor.authorVergote, Ignace
dc.contributor.authorMirza, Mansoor
dc.contributor.authorSehouli, Jalid
dc.contributor.authorLorusso, Domenica
dc.contributor.authorKose, Fatih
dc.contributor.authorCibula, David
dc.contributor.authorWestermann, Anneke
dc.contributor.authorCollins, Dearbhaile
dc.contributor.authorBanerjee, Susana
dc.contributor.authorOaknin, Ana
dc.contributor.authorSoumaoro, Ibrahima
dc.contributor.authorJain, Shweta
dc.contributor.authorMonk, Bradley
dc.date.accessioned2023-09-14T10:55:38Z
dc.date.available2023-09-14T10:55:38Z
dc.date.issued2022
dc.identifier.eissn1525-1438en_US
dc.identifier.endpageA225en_US
dc.identifier.issn1048-891Xen_US
dc.identifier.issueSupplement 3en_US
dc.identifier.startpageA225en_US
dc.identifier.urihttps://ijgc.bmj.com/content/ijgc/32/Suppl_3/A225.1.full.pdf
dc.identifier.urihttp://hdl.handle.net/11727/10659
dc.identifier.volume32en_US
dc.identifier.wos000899252300469en_US
dc.language.isoengen_US
dc.relation.isversionof10.1136/ijgc-2022-igcs.513en_US
dc.relation.journalINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCERen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.titleTrial in Progress of Engot-Cx8/Gog-3024/Innovatv 205: Addition of A New Cohort Using First-Line Tisotumab Vedotin Plus Pembrolizumab Plus Carboplatin +/- Bevacizumab in Recurrent/Metastatic Cervical Canceren_US
dc.typeConference Objecten_US

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
ae30.pdf
Size:
56.69 KB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: